-

07:01:44 AM

STIM Stock News

STIM - Neuronetics Inc

08/05/22 4:30 PM

Nasdaq : STIM

Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, today announced the

RHEA-AI

very positive

08/02/22 8:00 AM

Nasdaq : STIM

Neuronetics Reports Second Quarter 2022 Financial and Operating Results

Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company with a strategic vision of transforming the lives of patients whenever and wherever they need help with the best neurohealth therapies in the world, today announced its

RHEA-AI

positive

07/28/22 4:30 PM

Nasdaq : STIM

conferences

Neuronetics to Present at the Canaccord Genuity 42nd Annual Growth Conference

Neuronetics, Inc. (NASDAQ: STIM), a commercial-stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurological health disorders, today announced

RHEA-AI

neutral

07/25/22 8:31 AM

Nasdaq : STIM

partnership

Neuronetics and Alleviant Health Centers Announce Exclusive Partnership

Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that

RHEA-AI

positive

07/19/22 8:30 AM

Nasdaq : STIM

conferences

Neuronetics to Report Second Quarter 2022 Financial and Operating Results and Host Conference Call

Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, today announced that it

RHEA-AI

neutral

07/19/22 7:00 AM

Nasdaq : STIM

NeuroStar® Advanced Therapy for Mental Health Receives FDA Clearance for Treatment of Anxious Depression

Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products

RHEA-AI

neutral

07/13/22 8:31 AM

Nasdaq : STIM

Neuronetics Recognized as Top Non-Invasive Devices Provider in 2022

Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products

RHEA-AI

neutral

07/11/22 4:46 PM

Nasdaq : STIM

Neuronetics Announces Positive TMS Coverage Policies to Expand Patient Access to NeuroStar TMS Therapy for Mental Health

Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company with a strategic vision of transforming the

RHEA-AI

neutral

05/25/22 4:30 PM

Nasdaq : STIM

conferences

Neuronetics to Present at the William Blair 42nd Annual Growth Stock Conference

Neuronetics, Inc. (NASDAQ: STIM), a commercial-stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurological health disorders, today announced that

RHEA-AI

neutral

05/17/22 8:31 AM

Nasdaq : STIM

New Peer-Reviewed Data Continue to Further Best Practices with NeuroStar® Advanced Therapy

Neuronetics, Inc. (NASDAQ: STIM), a commercial-stage medical technology company focused on designing, developing, and marketing products that

RHEA-AI

positive

1 2 3 4 5 6 7 8 9 10 Next

STIM Data

IndustrySurgical and Medical Instrument Manufacturing
Websitewww.neuronetics.com
Security nameNeuronetics Inc
Issue typecs
SectorManufacturing
Sic code3841
Employees126
Tags
- Health Technology
- Medical Specialties
- Manufacturing
- Surgical and Medical Instrument Manufacturing
Address3222 Phoenixville Pike
StatePennsylvania
CityMalvern
Zip19355-9615
CountryUS
Phone18776007555

About Neuronetics Inc

Neuronetics, Inc. is a commercial-stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its commercial product, the NeuroStar® Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulation, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The system is cleared by the United States Food and Drug Administration, or FDA, for the treatment of major depressive disorder in adult patients who have failed to achieve satisfactory improvement from prior antidepressant medication in the current episode. Visit NeuroStar.com for safety information and indications for use. NeuroStar is also available in other parts of the world, including Japan, where it is listed under Japan's national health insurance.